Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research

Go back to Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research
(NYSE: MANE) Delayed: 102.79 +8.92 (9.50%)
Previous Close $93.87    52 Week High
Open $96.03    52 Week Low
Day High $106.00    P/E N/A 
Day Low $95.93    EPS
Volume 896,756